☰

Sukrut Somani - Publications

Affiliations: 
2010-2011 The School of Pharmacy University of London, London, England, United Kingdom 
 2012- University of Strathclyde, Glasgow, Scotland, United Kingdom 
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Maeyouf K, Sakpakdeejaroen I, Somani S, Meewan J, Ali-Jerman H, Laskar P, Mullin M, MacKenzie G, Tate RJ, Dufès C. Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells. Pharmaceutics. 15. PMID 38004621 DOI: 10.3390/pharmaceutics15112643  0.835
2022 Meewan J, Somani S, Almowalad J, Laskar P, Mullin M, MacKenzie G, Khadke S, Perrie Y, Dufès C. Preparation of Zein-Based Nanoparticles: Nanoprecipitation versus Microfluidic-Assisted Manufacture, Effects of PEGylation on Nanoparticle Characteristics and Cellular Uptake by Melanoma Cells. International Journal of Nanomedicine. 17: 2809-2822. PMID 35791309 DOI: 10.2147/IJN.S366138  0.73
2022 Almowalad J, Laskar P, Somani S, Meewan J, Tate RJ, Dufès C. Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells. International Journal of Nanomedicine. 17: 1409-1421. PMID 35369035 DOI: 10.2147/IJN.S347574  0.777
2022 Meewan J, Somani S, Laskar P, Irving C, Mullin M, Woods S, Roberts CW, Alzahrani AR, Ferro VA, McGill S, Weidt S, Burchmore R, Dufès C. Limited Impact of the Protein Corona on the Cellular Uptake of PEGylated Zein Micelles by Melanoma Cancer Cells. Pharmaceutics. 14. PMID 35214171 DOI: 10.3390/pharmaceutics14020439  0.81
2021 Almowalad J, Somani S, Laskar P, Meewan J, Tate RJ, Mullin M, Dufès C. Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro. International Journal of Nanomedicine. 16: 4391-4407. PMID 34234433 DOI: 10.2147/IJN.S316830  0.788
2021 Sakpakdeejaroen I, Somani S, Laskar P, Mullin M, Dufès C. Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles. International Journal of Nanomedicine. 16: 2615-2631. PMID 33854311 DOI: 10.2147/IJN.S293480  0.814
2021 Laskar P, Somani S, Mullin M, Tate RJ, Warzecha M, Bowering D, Keating P, Irving C, Leung HY, Dufès C. Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells. Biomaterials Science. PMID 33404026 DOI: 10.1039/d0bm01441a  0.817
2020 Sakpakdeejaroen I, Somani S, Laskar P, Irving C, Mullin M, Dufès C. Anti-Tumor Activity of Intravenously Administered Plumbagin Entrapped in Targeted Nanoparticles. Journal of Biomedical Nanotechnology. 16: 85-100. PMID 31996288 DOI: 10.1166/jbn.2020.2874  0.828
2019 Rushworth LK, Hewit K, Munnings-Tomes S, Somani S, James D, Shanks E, Dufès C, Straube A, Patel R, Leung HY. Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment. British Journal of Cancer. PMID 31844184 DOI: 10.1038/S41416-019-0681-5  0.383
2019 Laskar P, Somani S, Campbell SJ, Mullin M, Keating P, Tate RJ, Irving C, Leung HY, Dufès C. Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. Nanoscale. PMID 31612185 DOI: 10.1039/c9nr07254c  0.825
2019 Sakpakdeejaroen I, Somani S, Laskar P, Mullin M, Dufès C. Transferrin-bearing liposomes entrapping plumbagin for targeted cancer therapy. Journal of Interdisciplinary Nanomedicine. 4: 54-71. PMID 31341642 DOI: 10.1002/jin2.56  0.83
2019 Sakpakdeejaroen I, Somani S, Mullin M, Dufès C. Development of transferrin-bearing vesicles encapsulating aspirin for cancer therapy. Journal of Liposome Research. 1-30. PMID 31060409 DOI: 10.1080/08982104.2019.1614054  0.808
2018 Laskar P, Somani S, Altwaijry N, Mullin M, Bowering D, Warzecha M, Keating P, Tate RJ, Leung HY, Dufès C. Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells. Nanoscale. PMID 30488937 DOI: 10.1039/c8nr08141g  0.826
2018 Altwaijry N, Somani S, Dufès C. Targeted nonviral gene therapy in prostate cancer. International Journal of Nanomedicine. 13: 5753-5767. PMID 30310278 DOI: 10.2147/IJN.S139080  0.809
2018 Obeid MA, Dufès C, Somani S, Mullen AB, Tate RJ, Ferro VA. Proof of concept studies for siRNA delivery by non-ionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown. Journal of Liposome Research. 1-27. PMID 30296860 DOI: 10.1080/08982104.2018.1531424  0.306
2018 Somani S, Laskar P, Altwaijry N, Kewcharoenvong P, Irving C, Robb G, Pickard BS, Dufès C. PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells. Scientific Reports. 8: 9410. PMID 29925967 DOI: 10.1038/s41598-018-27400-6  0.76
2018 Altwaijry N, Somani S, Parkinson JA, Tate RJ, Keating P, Warzecha M, Mackenzie GR, Leung HY, Dufès C. Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12. Drug Delivery. 25: 679-689. PMID 29493296 DOI: 10.1080/10717544.2018.1440666  0.785
2016 Karim R, Somani S, Al Robaian M, Mullin M, Amor R, McConnell G, Dufès C. Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27993600 DOI: 10.1016/j.jconrel.2016.12.014  0.799
2015 Somani S, Dufès C. Transferrin-bearing dendrimers for cancer therapy: an update. Nanomedicine (London, England). 10: 2125-7. PMID 26096751 DOI: 10.2217/nnm.15.93  0.396
2015 Lim LY, Koh PY, Somani S, Al Robaian M, Karim R, Yean YL, Mitchell J, Tate RJ, Edrada-Ebel R, Blatchford DR, Mullin M, Dufès C. Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 1445-54. PMID 25933695 DOI: 10.1016/j.nano.2015.04.006  0.831
2015 Somani S, Dufès C. Transferrin-bearing dendrimers for cancer therapy: An update Nanomedicine. 10: 2125-2127. DOI: 10.2217/nnm.15.93  0.396
2014 Somani S, Dufès C. Applications of dendrimers for brain delivery and cancer therapy Nanomedicine. 9: 2403-2414. PMID 25413857 DOI: 10.2217/nnm.14.130  0.472
2013 Dufès C, Robaian MA, Somani S. Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells Therapeutic Delivery. 4: 629-640. PMID 23647279 DOI: 10.4155/tde.13.21  0.79
Show low-probability matches.